Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.18 -0.03 (-2.48%)
At close: Aug 21, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Long-Term Deferred Tax (2020 - 2024)

Phio Pharmaceuticals' (PHIO) quarterly Long-Term Deferred Tax came in at $2.6 million in Q4 2023, down 74.8% on a QoQ basis from $10.2 million in Q4 2021.

Phio Pharmaceuticals (PHIO) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends

Phio Pharmaceuticals (PHIO) has 3 years of Long-Term Deferred Tax data on file, last reported at $2.6 million in Q4 2023.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.6 million (changed N/A YoY) and the FY2023 annual result came in at $2.6 million, changed N/A from the prior year.
  • Long-Term Deferred Tax fell to $2.6 million in Q4 2023, from $10.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.2 million in Q4 2021 to a low of $2.6 million in Q4 2023.
  • A 3-year average of $6.4 million and a median of $6.4 million in 2020 frame the typical range for Long-Term Deferred Tax.
  • The widest YoY moves for Long-Term Deferred Tax: up 59.72% in 2021, down 59.72% in 2021.
  • Tracing PHIO's Long-Term Deferred Tax over 3 years: stood at $6.4 million in 2020, then surged by 59.72% to $10.2 million in 2021, then plunged by 74.8% to $2.6 million in 2023.
  • The last three Long-Term Deferred Tax figures came in at $2.6 million (Q4 2023), $10.2 million (Q4 2021), and $6.4 million (Q4 2020), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Phio Pharmaceuticals 13.77 Mn 13.77 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 350,000.00
Dec 31, 2023 2.56 Mn
Dec 31, 2021 10.15 Mn
Dec 31, 2020 6.36 Mn